In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors

scientific article published on 2 June 2009

In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ACTATROPICA.2009.05.018
P698PubMed publication ID19497287
P5875ResearchGate publication ID26267526

P50authorKesara Na-BangchangQ89291515
Wanna ChaijaroenkulQ115897775
P2093author name stringRaewadee Wisedpanichkij
Kanyarat Boonprasert
Jintana Tantisawat
Piyanan Sangsuwan
P433issue1
P921main subjectantimalarialQ521616
mefloquineQ736270
P304page(s)12-15
P577publication date2009-06-02
P1433published inActa TropicaQ15762560
P1476titleIn vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors
P478volume112

Reverse relations

cites work (P2860)
Q45907681Antimalarial interaction of quinine and quinidine with clarithromycin.
Q34084173Artemisone effective against murine cerebral malaria
Q47985538Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice
Q43050264Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole
Q42493268Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica
Q42485937Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica
Q27861940Structural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugs

Search more.